`a`
Mathematical Biosciences and Engineering (MBE)
 

A mathematical model for antibiotic control of bacteria in peritoneal dialysis associated peritonitis
Pages: 1449 - 1464, Issue 6, December 2014

doi:10.3934/mbe.2014.11.1449      Abstract        References        Full text (440.1K)           Related Articles

Colette Calmelet - Department of Mathematics and Statistics, California State University, Holt Hall 181, Chico, CA 95929, United States (email)
John Hotchkiss - Departments of Critical Care Medicine and Medicine, University of Pittsburgh and Pittsburgh Veterans Affairs Healthcare System, 644A Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, United States (email)
Philip Crooke - Departments of Critical Care Medicine and Medicine, University of Pittsburgh Pittsburgh Veterans Affairs Healthcare System, 644A Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, United States (email)

1 M. Bouvier D’Yvoire and P. Maire, Dosage regimens of antibacterials: Implications of a pharmacokinetic/pharmacodynamic model, Clin. Drug. Invest., 11 (1996), 229-239.
2 E. M. C. D’Agata, Antimicrobial-resistant, gram positive bacteria among patients undergoing chronic hemodialysis, Clin. Infect. Dis., 15 (2002), 1212-1218.
3 J. T. Daugirdas, P. G. Blake and T. S. Ing, Physiology of Peritoneal Dialysis. Handbook of Dialysis, Lippincott Williams & Wilkins, 2011.
4 E. D. Hermsen, L. B. Hovde, J. R. Hotchkiss and J. C. Rotschafer, Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vito peritoneal dialysate model, Antimicrobial Agents Chemotherapy, 47 (2003), 3764-3767.
5 S. Hota, P. S. Crooke and J. R. Hotchkiss, A Monte Carlo analysis of peritoneal antimicrobial pharmacokinetics, Adv. Exp. Med. Biol., 696 (2011), 401-410.
6 J. R. Hotchkiss, E. D. Hermsen and L. B. Hovde, et al., Dynamic analysis of peritoneal dialysis associated peritonitis, ASAIO Journal, (2004), 568-576.
7 Q. Khairullah, R. Provenzano, J. Tayeb and A. Ahmad, et al., Comparison of vancomycin versus cefazolin as inititial therapy for peritonitis in peritoneal dialysis patients, Peritoneal Dialysis International, 22 (2002), 339-344.
8 J. K. Leypoldt and C. D. Mistry, Ultrafiltration in peritoneal dialysis, in The Textbook of Peritoneal Dialysis, Kluwer Academic Publishers, 1994, 135-160.
9 S. Millikin, G. Matzke and W. Keane, Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis, Peritoneal Dialysis International, 11 (1991), 252-260.
10 E. Nielsen and L. Friberg, Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs, Pharmacol. Rev., 65 (2013), 1053-1090.
11 R. R. Regoes, et al., Pharmacodynamic functions: A multiparameter approach to the design of antibiotic treatment regimens, Antimicrob. Agents & Chemo., 48 (2004), 3670-3676.
12 T. Tozer and M. Rowland, Introduction to Pharmacokinetics and Pharmacodynamics: The Quantitative Basis of Drug Therapy, Lippincott Williams & Wilkins, 2006.
13 J. Zhi, C. H. Nightingale and R. Quintiliani, A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions, J. Pharm. Sci., 75 (1986), 1063-1067.

Go to top